STVN
Stevanato Group S.p.A.NYSEHealthcare$13.73-0.15%ClosedMarket Cap: $3.75B
As of 2026-04-06
Valuation
P/E (TTM)
26.88
PEG
1.46
P/B
2.19
P/S
2.76
EV/EBITDA
12.74
DCF Value
$-9.11
FCF Yield
0.5%
Div Yield
0.4%
Margins & Returns
Gross Margin
29.0%
Operating Margin
16.5%
Net Margin
11.8%
ROE
9.7%
ROA
5.5%
ROIC
6.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $343.3M | 30.9% | $66.0M | $47.2M | $0.17 | — |
| FY 2025 | $1.14B | 29.0% | $183.1M | $134.3M | $0.49 | $0.06 |
| Q3 2025 | $303.2M | 29.2% | $52.7M | $36.1M | $0.13 | — |
| Q2 2025 | $280.0M | 28.1% | $41.4M | $29.7M | $0.11 | $0.06 |
| Q1 2025 | $256.6M | 27.2% | $34.6M | $26.5M | $0.10 | — |
| Q4 2024 | $330.6M | 29.7% | $66.9M | $48.3M | $0.18 | — |
| FY 2024 | $1.10B | 27.4% | $161.1M | $117.8M | $0.43 | $0.06 |
| Q3 2024 | $277.9M | 26.8% | $41.0M | $30.0M | $0.11 | — |
| Q2 2024 | $259.6M | 26.0% | $28.0M | $20.6M | $0.08 | $0.06 |
| Q1 2024 | $236.0M | 26.4% | $25.3M | $18.8M | $0.07 | — |
| Q4 2023 | $320.6M | 31.8% | $64.0M | $45.2M | $0.17 | — |
| FY 2023 | $1.09B | 31.3% | $200.7M | $145.6M | $0.55 | $0.06 |